Terms: = Endocrine gland cancer AND PPM1D, Wip1, 8493, ENSG00000170836, O15297, WIP1, PP2C-DELTA
28 results:
1. A Case Study on ppm1d and 9 Other Shared Germline Alterations in a Family.
Biswas S; Manekar S; Bakshi SR
Asian Pac J Cancer Prev; 2023 Jun; 24(6):2129-2134. PubMed ID: 37378944
[TBL] [Abstract] [Full Text] [Related]
2. Extracranial germ cell tumours in children and adolescents: Results from the French TGM13 protocol.
Faure-Conter C; Orbach D; Sudour-Bonnange H; Verité C; Mansuy L; Rome A; Dumesnil C; Thebaud E; Renard M; Hameury F; Flechon A; Blanc E; Dijoud F; Fresneau B; Chabaud S
Pediatr Blood Cancer; 2023 Mar; 70(3):e30117. PubMed ID: 36451268
[TBL] [Abstract] [Full Text] [Related]
3. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
[TBL] [Abstract] [Full Text] [Related]
4. MS: wip1 suppresses angiogenesis through the STAT3-VEGF signalling pathway in serous ovarian cancer.
Yin S; Yang L; Zheng Y; Zang R
J Ovarian Res; 2022 May; 15(1):56. PubMed ID: 35538489
[TBL] [Abstract] [Full Text] [Related]
5. Clinical significance of gene polymorphisms for hereditary predisposition to breast and ovarian cancer (review of literature).
Vodolazhsky DI; Mayakovskaya AV; Kubyshkin AV; Aliev KA; Fomochkina II
Klin Lab Diagn; 2021 Dec; 66(12):760-767. PubMed ID: 35020290
[TBL] [Abstract] [Full Text] [Related]
6. Clonal Hematopoiesis-Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian cancer.
Weber-Lassalle K; Ernst C; Reuss A; Möllenhoff K; Baumann K; Jackisch C; Hauke J; Dietrich D; Borde J; Park-Simon TW; Hanker L; Prieske K; Schmidt S; Weber-Lassalle N; Pohl-Rescigno E; Kommoss S; Marmé F; Heitz F; Stingl JC; Schmutzler RK; Harter P; Hahnen E
J Natl Cancer Inst; 2022 Apr; 114(4):565-570. PubMed ID: 34963005
[TBL] [Abstract] [Full Text] [Related]
7. Moving towards a local testing solution for undetermined thyroid fine-needle aspirates: validation of a novel custom DNA-based NGS panel.
Sgariglia R; Nacchio M; Migliatico I; Vigliar E; Malapelle U; Pisapia P; De Luca C; Iaccarino A; Salvatore D; Masone S; Troncone G; Bellevicine C
J Clin Pathol; 2022 Jul; 75(7):465-471. PubMed ID: 33789920
[TBL] [Abstract] [Full Text] [Related]
8. A meta-analysis on the diagnostic value of diffusion-weighted imaging on ovarian cancer.
Dai G; Liang K; Xiao Z; Yang Q; Yang S
J BUON; 2019; 24(6):2333-2340. PubMed ID: 31983103
[TBL] [Abstract] [Full Text] [Related]
9. Silencing of ppm1d inhibits cell proliferation and invasion through the p38 MAPK and p53 signaling pathway in papillary thyroid carcinoma.
Lu ZW; Wen D; Wei WJ; Han LT; Xiang J; Wang YL; Wang Y; Liao T; Ji QH
Oncol Rep; 2020 Mar; 43(3):783-794. PubMed ID: 31922231
[TBL] [Abstract] [Full Text] [Related]
10. Somatic mosaic truncating mutations of ppm1d in blood can result from expansion of a mutant clone under selective pressure of chemotherapy.
Kim B; Won D; Lee ST; Choi JR
PLoS One; 2019; 14(6):e0217521. PubMed ID: 31242196
[TBL] [Abstract] [Full Text] [Related]
11. Multigene panel testing beyond BRCA1/2 in breast/ovarian cancer Spanish families and clinical actionability of findings.
Bonache S; Esteban I; Moles-Fernández A; Tenés A; Duran-Lozano L; Montalban G; Bach V; Carrasco E; Gadea N; López-Fernández A; Torres-Esquius S; Mancuso F; Caratú G; Vivancos A; Tuset N; Balmaña J; Gutiérrez-Enríquez S; Diez O
J Cancer Res Clin Oncol; 2018 Dec; 144(12):2495-2513. PubMed ID: 30306255
[TBL] [Abstract] [Full Text] [Related]
12. Absence of EIF1AX, ppm1d, and CHEK2 mutations reported in Thyroid cancer Genome Atlas (TCGA) in a large series of thyroid cancer.
Alzahrani AS; Murugan AK; Qasem E; Alswailem MM; AlGhamdi B; Moria Y; Al-Hindi H
Endocrine; 2019 Jan; 63(1):94-100. PubMed ID: 30269267
[TBL] [Abstract] [Full Text] [Related]
13. Multiple-gene panel analysis in a case series of 255 women with hereditary breast and ovarian cancer.
Tedaldi G; Tebaldi M; Zampiga V; Danesi R; Arcangeli V; Ravegnani M; Cangini I; Pirini F; Petracci E; Rocca A; Falcini F; Amadori D; Calistri D
Oncotarget; 2017 Jul; 8(29):47064-47075. PubMed ID: 28423363
[TBL] [Abstract] [Full Text] [Related]
14. wip1 suppresses ovarian cancer metastasis through the ATM/AKT/Snail mediated signaling.
Yin S; Wang P; Yang L; Liu Y; Wang Y; Liu M; Qi Z; Meng J; Shi TY; Yang G; Zang R
Oncotarget; 2016 May; 7(20):29359-70. PubMed ID: 27121065
[TBL] [Abstract] [Full Text] [Related]
15. Somatic Mosaic Mutations in ppm1d and TP53 in the Blood of Women With Ovarian Carcinoma.
Swisher EM; Harrell MI; Norquist BM; Walsh T; Brady M; Lee M; Hershberg R; Kalli KR; Lankes H; Konnick EQ; Pritchard CC; Monk BJ; Chan JK; Burger R; Kaufmann SH; Birrer MJ
JAMA Oncol; 2016 Mar; 2(3):370-2. PubMed ID: 26847329
[TBL] [Abstract] [Full Text] [Related]
16. ppm1d Mosaic Truncating Variants in Ovarian cancer Cases May Be Treatment-Related Somatic Mutations.
Pharoah PDP; Song H; Dicks E; Intermaggio MP; Harrington P; Baynes C; Alsop K; ; Bogdanova N; Cicek MS; Cunningham JM; Fridley BL; Gentry-Maharaj A; Hillemanns P; Lele S; Lester J; McGuire V; Moysich KB; Poblete S; Sieh W; Sucheston-Campbell L; Widschwendter M; ; Whittemore AS; Dörk T; Menon U; Odunsi K; Goode EL; Karlan BY; Bowtell DD; Gayther SA; Ramus SJ
J Natl Cancer Inst; 2016 Mar; 108(3):. PubMed ID: 26823519
[TBL] [Abstract] [Full Text] [Related]
17. ppm1d exerts its oncogenic properties in human pancreatic cancer through multiple mechanisms.
Wu B; Guo BM; Kang J; Deng XZ; Fan YB; Zhang XP; Ai KX
Apoptosis; 2016 Mar; 21(3):365-78. PubMed ID: 26714478
[TBL] [Abstract] [Full Text] [Related]
18. Comparison of chromogranin A (CgA) levels in serum and plasma (EDTA2K) and the respective reference ranges in healthy males.
Glinicki P; Jeske W; Kapuścińska R; Zgliczyński W
Endokrynol Pol; 2015; 66(1):53-6. PubMed ID: 25754282
[TBL] [Abstract] [Full Text] [Related]
19. Integrated genomic characterization of papillary thyroid carcinoma.
Cancer Genome Atlas Research Network
Cell; 2014 Oct; 159(3):676-90. PubMed ID: 25417114
[TBL] [Abstract] [Full Text] [Related]
20. MicroRNA-21 is a candidate driver gene for 17q23-25 amplification in ovarian clear cell carcinoma.
Hirata Y; Murai N; Yanaihara N; Saito M; Saito M; Urashima M; Murakami Y; Matsufuji S; Okamoto A
BMC Cancer; 2014 Nov; 14():799. PubMed ID: 25366985
[TBL] [Abstract] [Full Text] [Related]
[Next]
